ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 67 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,441,000 | -41.8% | 293,428 | -37.4% | 0.00% | -50.0% |
| Q2 2021 | $2,476,000 | +44.1% | 468,860 | +31.0% | 0.00% | 0.0% |
| Q1 2021 | $1,718,000 | -41.3% | 357,892 | -47.1% | 0.00% | -33.3% |
| Q4 2020 | $2,928,000 | +19.7% | 676,126 | +13.8% | 0.00% | 0.0% |
| Q3 2020 | $2,447,000 | +419.5% | 593,947 | +222.6% | 0.00% | +200.0% |
| Q2 2020 | $471,000 | +110.3% | 184,100 | +137.3% | 0.00% | – |
| Q1 2020 | $224,000 | -39.0% | 77,583 | +8.2% | 0.00% | – |
| Q3 2019 | $367,000 | -23.1% | 71,724 | +218.4% | 0.00% | -100.0% |
| Q3 2017 | $477,000 | -51.1% | 22,526 | -34.7% | 0.00% | 0.0% |
| Q4 2015 | $976,000 | +225.3% | 34,474 | +92.2% | 0.00% | – |
| Q3 2015 | $300,000 | +24.5% | 17,936 | +38.3% | 0.00% | – |
| Q3 2014 | $241,000 | -60.5% | 12,969 | -61.2% | 0.00% | -100.0% |
| Q2 2014 | $610,000 | – | 33,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |